Vacci-Test-Tetanus is a rapid, sensitive, lateral flow diagnostic assay that determines the immune status of an individual by detecting the presence of circulating antibodies.
The Vacci-Test-Tetanus is being distributed by Groupe ServioBio, one of Europe’s distributors of point-of-care diagnostic tests to hospitals and emergency clinics.
Bernard Boyer, managing director of Vacci-Test, said: “We are confident that our new product will become the assay of choice as a rapid, reliable point-of-care tetanus test and will avoid the need and expense of unnecessary revaccination.”